Search results

From Proteopedia

You searched for Nivolumab

Jump to: navigation, search

There is no page with the exact title "Nivolumab". The search results for "Nivolumab" are displayed below. You can create a page titled Nivolumab (by clicking on the red link).

For more information about searching Proteopedia, see Help.

Showing below 17 results starting with #1.


View (previous 20) (next 20) (20 | 50 | 100 | 250 | 500)

Article title matches

  1. Category:Nivolumab (40 bytes)
    1: List of pages with the keyword Nivolumab

Page text matches

  1. 7e9b (3,856 bytes)
    11: ...amino acid residues on PD-1. We compared HLX10 to Nivolumab and Pembrolizumab and it showed similar or better...
  2. 9hk1 (4,913 bytes)
    16: ...ensitivity in experimental models. Paradoxically, nivolumab and pembrolizumab, anti-PD-1-blocking antibodies ...
  3. User:Tiphaine Wong (1,224 bytes)
    13: Nivolumab (Opdivo, Bristol-Myers Squibb), an antibody-drug,...
  4. Sandbox Reserved 1133 (8,053 bytes)
    53: Nivolumab (Opdivo, Bristol-Myers Squibb), an antibody-drug,...
  5. 5ggq (3,044 bytes)
    2: ==Crystal structure of Nivolumab Fab fragment==
    11: ...ic antibodies, including PD-1/pembrolizumab, PD-1/nivolumab, PD-L1/BMS-936559 and CTLA-4/tremelimumab. These ...
  6. 5ggr (4,290 bytes)
    2: ==PD-1 in complex with nivolumab Fab==
    15: ...ic antibodies, including PD-1/pembrolizumab, PD-1/nivolumab, PD-L1/BMS-936559 and CTLA-4/tremelimumab. These ...
  7. 5ggs (4,296 bytes)
    15: ...ic antibodies, including PD-1/pembrolizumab, PD-1/nivolumab, PD-L1/BMS-936559 and CTLA-4/tremelimumab. These ...
  8. 5ggu (3,040 bytes)
    11: ...ic antibodies, including PD-1/pembrolizumab, PD-1/nivolumab, PD-L1/BMS-936559 and CTLA-4/tremelimumab. These ...
  9. 5ggv (5,268 bytes)
    15: ...ic antibodies, including PD-1/pembrolizumab, PD-1/nivolumab, PD-L1/BMS-936559 and CTLA-4/tremelimumab. These ...
  10. 5wt9 (4,705 bytes)
    2: ==Complex structure of PD-1 and nivolumab-Fab==
    16: ...-glycosylation is not involved in binding at all. Nivolumab binds to a completely different area than pembrol...
    18: ...cted N-terminal loop in PD-1 dominates binding by nivolumab.,Tan S, Zhang H, Chai Y, Song H, Tong Z, Wang Q, ...
  11. Category:Nivolumab (40 bytes)
    1: List of pages with the keyword Nivolumab
  12. 8eq6 (4,734 bytes)
    15: ...ensitivity in experimental models. Paradoxically, nivolumab and pembrolizumab, anti-PD-1-blocking antibodies ...
  13. 6hig (4,432 bytes)
    15: ...s (Abs) targeting PD-1, such as pembrolizumab and nivolumab, act through blockade of the PD-1-PDL-1 interacti...
  14. 6jjp (4,773 bytes)
    16: ... the first two approved clinical PD-1 antibodies, nivolumab and pembrolizumab. These results suggest MW11-h31...
  15. 7um3 (4,954 bytes)
    13: ... superior progression-free survival compared with nivolumab monotherapy in patients with unresectable or meta...
    15: ...3-Blocking Antibody, Alone or in Combination with Nivolumab.,Thudium K, Selby M, Zorn JA, Rak G, Wang XT, Bun...
  16. 8as0 (5,322 bytes)
    16: ...n EC(50) value which was comparable to the one of nivolumab, a clinically approved antibody. The fine details...

View (previous 20) (next 20) (20 | 50 | 100 | 250 | 500)



Search in namespaces:

List redirects
Search for
Views
Personal tools